Helicobacter pylori
Conditions
Interventions
Test group:fecal PCR resistance gene testing
Control group:Routine treatment
Sponsors
Civil Aviation General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Urea breath test was positive and stool HP-PCR was positive; 2. Patients with digestive tract symptoms; 3. Has not previously received eradication treatment for Helicobacter pylori; 4. Age: 18-75 years old; 5. Fully informed and agreed to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patient had taken drugs that may affect the results of this study, such as proton pump inhibitors, H2 receptor antagonists, bismuth agents, or antibiotics for 4 weeks before enrollment; 2. Patients with malignant tumors of the digestive tract; 3. Patients who had undergone upper gastrointestinal surgery; 4. Those with severe concomitant diseases who cannot tolerate treatment; 5. Patients with severe liver and kidney dysfunction, cardiovascular and cerebrovascular diseases, and psychosis; 6. Patients who are allergic to the drugs used in this study; 7. Pregnant or lactating women; 8. Patients with other medical conditions that may increase adverse reactions to treatment (such as alcohol abuse).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse reactions rate;Degree of symptom relief; | — |
Countries
China
Contacts
Public ContactJianping Cheng
Civil Aviation General Hospital
Outcome results
None listed